Cargando…
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection
The spread of antibiotic resistant-pathogens is driving the search for new antimicrobial compounds. Pulmonary infections experienced by cystic fibrosis (CF) patients are a dramatic example of this health-care emergency. Antimicrobial peptides could answer the need for new antibiotics but translating...
Autores principales: | Mardirossian, Mario, Pompilio, Arianna, Degasperi, Margherita, Runti, Giulia, Pacor, Sabrina, Di Bonaventura, Giovanni, Scocchi, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474674/ https://www.ncbi.nlm.nih.gov/pubmed/28674688 http://dx.doi.org/10.3389/fchem.2017.00040 |
Ejemplares similares
-
The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity
por: Degasperi, Margherita, et al.
Publicado: (2020) -
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections
por: Degasperi, Margherita, et al.
Publicado: (2022) -
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
por: Pompilio, Arianna, et al.
Publicado: (2012) -
Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against Pseudomonas aeruginosa From Cystic Fibrosis Patients
por: Di Bonaventura, Giovanni, et al.
Publicado: (2022) -
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens
por: Pompilio, Arianna, et al.
Publicado: (2018)